Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Developing new contraceptives [[electronic resource] ] : obstacles and opportunities / / Luigi Mastroianni, Jr., Peter J. Donaldson, and Thomas T. Kane, editors
| Developing new contraceptives [[electronic resource] ] : obstacles and opportunities / / Luigi Mastroianni, Jr., Peter J. Donaldson, and Thomas T. Kane, editors |
| Pubbl/distr/stampa | Washington, D.C., : National Academy Press, 1990 |
| Descrizione fisica | 1 online resource (205 p.) |
| Disciplina | 613.9/4 |
| Altri autori (Persone) |
MastroianniLuigi
DonaldsonPeter J KaneThomas T. <1951-> |
| Soggetto topico |
Contraceptives - Research - United States
Contraceptive drugs - Research - United States |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-280-21282-9
9786610212828 0-309-56452-2 0-585-15520-8 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910455926003321 |
| Washington, D.C., : National Academy Press, 1990 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Developing new contraceptives : obstacles and opportunities / / editors, Luigi Mastroianni, Jr., Peter J. Donaldson, Thomas T. Kane
| Developing new contraceptives : obstacles and opportunities / / editors, Luigi Mastroianni, Jr., Peter J. Donaldson, Thomas T. Kane |
| Pubbl/distr/stampa | Washington, D.C. : , : National Academy Press, , 1990 |
| Descrizione fisica | 1 online resource (205 pages) : illustrations |
| Disciplina | 613.9/4 |
| Altri autori (Persone) |
MastroianniLuigi
DonaldsonPeter J KaneThomas T. <1951-> |
| Soggetto topico |
Contraceptives - Research - United States
Contraceptive drugs - Research - United States |
| ISBN |
1-280-21282-9
9786610212828 0-309-56452-2 0-585-15520-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910778786503321 |
| Washington, D.C. : , : National Academy Press, , 1990 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Developing new contraceptives : obstacles and opportunities / / Luigi Mastroianni, Jr., Peter J. Donaldson, and Thomas T. Kane, editors
| Developing new contraceptives : obstacles and opportunities / / Luigi Mastroianni, Jr., Peter J. Donaldson, and Thomas T. Kane, editors |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Washington, D.C., : National Academy Press, 1990 |
| Descrizione fisica | 1 online resource (205 pages) : illustrations |
| Disciplina | 613.9/4 |
| Altri autori (Persone) |
MastroianniLuigi
DonaldsonPeter J KaneThomas T. <1951-> |
| Soggetto topico |
Contraceptives - Research - United States
Contraceptive drugs - Research - United States |
| ISBN |
1-280-21282-9
9786610212828 0-309-56452-2 0-585-15520-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Developing New Contraceptives -- Copyright -- Preface -- Acknowledgments -- Contents -- Executive Summary -- THE NEED FOR NEW CONTRACEPTIVES -- FDA REGULATION OF CONTRACEPTIVE PRODUCTS -- PRODUCTS LIABILITY LAW AFFECTING CONTRACEPTIVES -- CONCLUSION -- 1 Introduction -- ORGANIZATION -- 2 The Need for New Contraceptives -- CURRENT CONTRACEPTIVE USE -- Contraceptive Practice -- Contraceptive Effectiveness -- POTENTIAL EFFECTS OF NEW CONTRACEPTIVES -- Reducing Abortions -- Contraception and Health -- Reducing the Problems Associated with Existing Methods -- Increasing the Coverage and Quality of Contraceptive Services -- THE IMPORTANCE OF CONTRACEPTIVE DELIVERY -- CONCLUSION -- 3 The Current Status of Contraceptive Research -- RESEARCH LEADS -- Female Methods -- Male Methods -- Modifications of Existing Methods -- METHODS AVAILABLE OUTSIDE THE UNITED STATES -- CONCLUSION -- 4 Values and Contraceptive Development -- ROOTS OF AMERICAN VALUES ON CONTRACEPTION -- Historical Perspectives -- Religious Perspectives -- Legal Perspectives -- CONTEMPORARY VALUE CONFLICTS: STERILIZATION AND ABORTION -- The Link Between Contraceptive Development and Abortion -- RU-486 -- WOMEN'S PERSPECTIVES ON REPRODUCTION AND SOCIAL ROLES -- CONCLUSION -- 5 Organizational Structure of Contraceptive Development -- A DIVERSITY OF EXPERTISE -- The Pharmaceutical Industry -- Small Firms -- Universities -- Nonprofit Organizations -- Government and Private Funding Organizations -- The World Health Organization -- COLLABORATIVE EFFORTS IN CONTRACEPTIVE DEVELOPMENT -- Industry-University Collaboration -- Competitive Aspects of Contraceptive Development -- International Collaboration -- STRENGTHENING THE PROCESS OF CONTRACEPTIVE DEVELOPMENT -- Developing Country Institutions -- National Scientific Centers in the United States -- CONCLUSION -- 6 Funding for Contraceptive Development.
FUNDING FOR CONTRACEPTIVE DEVELOPMENT -- Pharmaceutical Industry Funding -- Federal Funding -- Foundation Funding -- Funding Worldwide -- World Health Organization -- TRAINING -- RECOMMENDATIONS -- CONCLUSION -- 7 Regulation and Contraceptive Development -- THE DEVELOPMENT PROCESS -- THE REGULATION PROCESS -- FDA's Regulation of Drugs -- Standards of Approval: Safety -- Toxicological Testing of Contraceptive Drugs -- The Case of Depo-Provera -- The Appropriateness of Current Safety Requirements for Contraceptive Drugs -- Standards of Approval: Effectiveness -- The Risk-Benefit Trade-off -- Patent Life and Profitability -- FDA's Regulation of Medical Devices -- Impediments to FDA Approval -- Postmarketing Surveillance -- CONTRACEPTIVE REGULATION: AN INTERNATIONAL PERSPECTIVE -- Regulation in Europe -- Regulation in Developing Countries -- The World Health Organization's Role -- RECOMMENDATIONS -- CONCLUSION -- 8 Products Liability and Contraceptive Development -- THE LEGAL TERRAIN -- SOURCES OF DATA -- TRENDS IN LITIGATION INVOLVING CONTRACEPTIVES -- Intrauterine Devices -- Oral Contraceptives -- Other Contraceptives -- PRODUCTS LIABILITY RULES -- Warranty -- Fraudulent Misrepresentation -- Negligence -- Strict Liability in Tort -- CASE STUDIES -- The Dalkon Shield Intrauterine Device -- Other Intrauterine Devices -- Oral Contraceptives -- Other Contraceptives -- PRODUCTS LIABILITY INSURANCE AND CONTRACEPTIVE DEVELOPMENT -- Causes of the Insurance Crisis -- Cost and Availability of Liability Insurance for Contraceptives -- Responses to the Crisis -- Responses by Insurers -- Responses by Policy Holders -- Responses by State Legislatures -- CONCLUSIONS AND RECOMMENDATIONS -- Possible Elements of a Statute -- The FDA Defense -- Effect on Products Liability Cases -- CONCLUSION -- 9 Contraceptive Development: Obstacles and Opportunities. THE NEED FOR NEW METHODS -- RESEARCH LEADS -- VALUES -- ORGANIZATIONS AND RESOURCES -- REGULATION -- LIABILITY -- A FINAL WORD -- References -- Legal Cases Related to Contraceptive Development -- Glossary -- Index. |
| Record Nr. | UNINA-9910818451503321 |
| Washington, D.C., : National Academy Press, 1990 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Hormone use in menopause & male andropause : a choice for women and men / / Sheldon J. Segal & Luigi Mastroianni, Jr
| Hormone use in menopause & male andropause : a choice for women and men / / Sheldon J. Segal & Luigi Mastroianni, Jr |
| Autore | Segal Sheldon J (Sheldon Jerome) |
| Pubbl/distr/stampa | Oxford, [England] : , : Oxford University Press, , 2003 |
| Descrizione fisica | 1 online resource (218 p.) |
| Disciplina | 612.665 |
| Soggetto topico |
Menopause
Middle-aged women - Health and hygiene Climacteric, Male Middle-aged men - Health and hygiene Climacteric |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-280-50304-1
9786610503049 0-19-803620-5 1-60256-687-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Commentary: The Women's Health Initiative Clinical Study; Contents; 1. Why do women have menopause?; 2. What are the signs of menopause?; 3. What is menopausal hormone therapy?; 4. Why should women consider hormone therapy?; 5. Risk-benefit ratio: Making the choice; 6. Can HT protect brain function and prevent Alzheimer's disease?; 7. Does the approach of menopause mean the end of fertility?; 8. Herbal products for menopause; 9. Can phytoestrogens, antioxidants, and vitamins replace HT?; 10. Sex and the aging woman; 11. What is the status of designer estrogens?
12. Is there a "male menopause"?13. Is testosterone the only androgen the body produces?; 14. Why should men consider androgen supplementation therapy?; 15. What are the AST choices for men?; 16. The first designer androgen for men; 17. Can men safely use AST?; 18. Should aging men use nonprescription androgens?; 19. Sex and the aging man; 20. Can AST help brain function in aging men?; Questions about menopause; Questions about andropause; Glossary of terms; References; Index |
| Record Nr. | UNINA-9910450314603321 |
Segal Sheldon J (Sheldon Jerome)
|
||
| Oxford, [England] : , : Oxford University Press, , 2003 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Hormone use in menopause & male andropause : a choice for women and men / / Sheldon J. Segal & Luigi Mastroianni, Jr
| Hormone use in menopause & male andropause : a choice for women and men / / Sheldon J. Segal & Luigi Mastroianni, Jr |
| Autore | Segal Sheldon J (Sheldon Jerome) |
| Pubbl/distr/stampa | Oxford, [England] : , : Oxford University Press, , 2003 |
| Descrizione fisica | 1 online resource (218 p.) |
| Disciplina | 612.665 |
| Soggetto topico |
Menopause
Middle-aged women - Health and hygiene Climacteric, Male Middle-aged men - Health and hygiene Climacteric |
| ISBN |
0-19-770711-4
1-280-50304-1 9786610503049 0-19-803620-5 1-60256-687-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Commentary: The Women's Health Initiative Clinical Study; Contents; 1. Why do women have menopause?; 2. What are the signs of menopause?; 3. What is menopausal hormone therapy?; 4. Why should women consider hormone therapy?; 5. Risk-benefit ratio: Making the choice; 6. Can HT protect brain function and prevent Alzheimer's disease?; 7. Does the approach of menopause mean the end of fertility?; 8. Herbal products for menopause; 9. Can phytoestrogens, antioxidants, and vitamins replace HT?; 10. Sex and the aging woman; 11. What is the status of designer estrogens?
12. Is there a "male menopause"?13. Is testosterone the only androgen the body produces?; 14. Why should men consider androgen supplementation therapy?; 15. What are the AST choices for men?; 16. The first designer androgen for men; 17. Can men safely use AST?; 18. Should aging men use nonprescription androgens?; 19. Sex and the aging man; 20. Can AST help brain function in aging men?; Questions about menopause; Questions about andropause; Glossary of terms; References; Index |
| Record Nr. | UNINA-9910783352503321 |
|
Segal Sheldon J (Sheldon Jerome)
|
||
| Oxford, [England] : , : Oxford University Press, , 2003 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Hormone use in menopause & male andropause : a choice for women and men / / Sheldon J. Segal & Luigi Mastroianni, Jr
| Hormone use in menopause & male andropause : a choice for women and men / / Sheldon J. Segal & Luigi Mastroianni, Jr |
| Autore | Segal Sheldon J (Sheldon Jerome) |
| Pubbl/distr/stampa | Oxford, [England] : , : Oxford University Press, , 2003 |
| Descrizione fisica | 1 online resource (218 p.) |
| Disciplina | 612.665 |
| Soggetto topico |
Menopause
Middle-aged women - Health and hygiene Climacteric, Male Middle-aged men - Health and hygiene Climacteric |
| ISBN |
0-19-770711-4
1-280-50304-1 9786610503049 0-19-803620-5 1-60256-687-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Commentary: The Women's Health Initiative Clinical Study; Contents; 1. Why do women have menopause?; 2. What are the signs of menopause?; 3. What is menopausal hormone therapy?; 4. Why should women consider hormone therapy?; 5. Risk-benefit ratio: Making the choice; 6. Can HT protect brain function and prevent Alzheimer's disease?; 7. Does the approach of menopause mean the end of fertility?; 8. Herbal products for menopause; 9. Can phytoestrogens, antioxidants, and vitamins replace HT?; 10. Sex and the aging woman; 11. What is the status of designer estrogens?
12. Is there a "male menopause"?13. Is testosterone the only androgen the body produces?; 14. Why should men consider androgen supplementation therapy?; 15. What are the AST choices for men?; 16. The first designer androgen for men; 17. Can men safely use AST?; 18. Should aging men use nonprescription androgens?; 19. Sex and the aging man; 20. Can AST help brain function in aging men?; Questions about menopause; Questions about andropause; Glossary of terms; References; Index |
| Record Nr. | UNINA-9910821188503321 |
|
Segal Sheldon J (Sheldon Jerome)
|
||
| Oxford, [England] : , : Oxford University Press, , 2003 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||